You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mel

Showing 1 - 25 of 366
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Melanoma Trial in Irvine, Newport Beach (AV-MEL-1)

Recruiting
  • Metastatic Melanoma
  • Irvine, California
  • +1 more
Dec 14, 2021

MDD Trial in Espoo, Helsinki, Turku (MEL-T01, MEL-S01)

Recruiting
  • Major Depressive Disorder
  • MEL-T01
  • MEL-S01
  • Espoo, Uusimaa, Finland
  • +5 more
Aug 4, 2022

Melanoma Trial in Charlottesville (Excision of clinically detected lymph node metastasis before any systemic therapy, Excision

Not yet recruiting
  • Melanoma
  • Excision of clinically detected lymph node metastasis before any systemic therapy
  • Excision of clinically detected lymph node metastasis after neoadjuvant systemic therapy
  • Charlottesville, Virginia
    Cancer Center at the University of Virginia
Apr 20, 2023

Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

Recruiting
  • Hematopoietic Malignancy
  • +2 more
  • Umbilical Cord Blood Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Nov 6, 2023

Acute Myeloid Leukemia in Remission, MDS, Chronic Myeloid Leukemia in Remission Trial in Belgium (Thymoglobulin, Melphalan,

Recruiting
  • Acute Myeloid Leukemia in Remission
  • +9 more
  • Antwerp, Belgium
  • +9 more
Oct 5, 2021

Relapse Rate After Allo-HSCT Trial in Shanghai (Flu-Bu-Mel)

Active, not recruiting
  • Relapse Rate After Allo-HSCT
  • Shanghai, China
  • +1 more
Jun 1, 2021

Locally Advanced or Metastatic Melanoma Trial (CBL0137, Ipilimumab, Nivolumab)

Not yet recruiting
  • Locally Advanced or Metastatic Melanoma
  • (no location specified)
Aug 10, 2022

Lymphoid Tumor Trial in Shanghai (Flu-Bu-Mel-E)

Recruiting
  • Lymphoid Neoplasm
  • Shanghai, China
    Blood & Marrow Transplantation Center, RuiJin Hospital
May 22, 2021

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total

Active, not recruiting
  • Acute Myeloid Leukemia
  • +17 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023

Multiple Myeloma Trial in Little Rock (myPRS, Induction 1 - MEL-10+CFZ-TD-PACE, First Transplant - MEL-80+CFZ-TD-PACE + PBSC

Terminated
Has Results
  • Multiple Myeloma
  • myPRS
  • +6 more
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
May 28, 2021

Lille Study for Childhood Health Promotion

Not yet recruiting
  • Overweight, Infant
  • +2 more
  • Educational program
  • (no location specified)
Apr 4, 2022

Acute Leukemia, Immune Deficiency Disorder, Congenital Hematological Disorder Trial in Rochester (radiation, drug, procedure)

Recruiting
  • Acute Leukemia
  • +9 more
  • Total Body Irradiation 1200 cGy
  • +7 more
  • Rochester, New York
    Wilmot Cancer Institute
Jun 20, 2022

Melanoma, Metastatic Melanoma Trial in Boston (Ipilimumab, Nivolumab, Troriluzole)

Recruiting
  • Melanoma
  • Metastatic Melanoma
  • Boston, Massachusetts
  • +1 more
Sep 17, 2021

Innovations in Placental Metabolism and Association With

Suspended
  • Pregnancy Complications
  • +2 more
    • Rio de Janeiro, Brazil
      Maternidade Escola da UFRJ
    Dec 13, 2021

    Melanoma Stage III, Melanoma Stage IV Trial in Washington, Boston, Pittsburgh (Dostarlimab (TSR-042) (singly), Dostarlimab

    Recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • Dostarlimab (TSR-042) (singly)
    • Dostarlimab (TSR-042) and TSR-022 (combination)
    • Washington, District of Columbia
    • +2 more
    Feb 22, 2022

    Advanced Melanoma Trial in Worldwide (IMC-F106C, Nivolumab, Nivolumab + Relatlimab)

    Not yet recruiting
    • Advanced Melanoma
    • IMC-F106C
    • +2 more
    • La Jolla, California
    • +61 more
    Oct 31, 2023

    Multiple Myeloma Trial in Little Rock (Velcade, Melphalan, Thalidomide)

    Active, not recruiting
    • Multiple Myeloma
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences
    Sep 7, 2021

    Refractory and/or Relapsed Metastatic Solid Tumors Trial in United States (Cyclophosphamide, Fludarabine, low dose total body

    Recruiting
    • Refractory and/or Relapsed Metastatic Solid Tumors
    • Saint Petersburg, Florida
    • +4 more
    Oct 29, 2021

    Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia Trial in Duarte (drug,

    Active, not recruiting
    • Autologous Hematopoietic Stem Cell Transplant Recipient
    • +4 more
    • Duarte, California
      City of Hope
    Mar 17, 2022

    Melanoma, Metastatic Melanoma, Mucosal Melanoma Trial in Houston, Charlottesville (Peptide Vaccine (LPV7) + Tetanus peptide,

    Unknown status
    • Melanoma
    • +2 more
    • Peptide Vaccine (LPV7) + Tetanus peptide
    • +3 more
    • Houston, Texas
    • +1 more
    Nov 15, 2020

    Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Fludarabine, busulfan and melphalan
    • Fludarabine and Busulfan
    • Fuzhou, Fujian, China
    • +8 more
    Aug 14, 2023

    Multiple Myeloma Trial in Wuhan (Total Marrow irradiation,TMI, Autologous hematopoietic stem cell transplantation)

    Recruiting
    • Multiple Myeloma
    • Total Marrow irradiation，TMI
    • Autologous hematopoietic stem cell transplantation
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Jul 24, 2023

    NSCLC (NSCLC), Renal Cell Carcinoma (RCC), Malignant Melanoma (MEL) Trial in Russian Federation (GNR-051)

    Recruiting
    • Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma (RCC), Malignant Melanoma (MEL)
    • GNR-051
    • Kazan, Russian Federation
    • +11 more
    Sep 21, 2021

    T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

    Terminated
    Has Results
    • T-cell Non-Hodgkin Lymphoma
    • Boston, Massachusetts
    • +1 more
    Jan 26, 2023

    Melanoma Trial in Charlottesville (Ipilimumab, 6MHP)

    Terminated
    Has Results
    • Melanoma
    • Charlottesville, Virginia
      Cancer Center at the University of Virginia
    Apr 21, 2020